Petros Pharmaceuticals Successfully Launches AI Tool In ...
Petros Pharmaceuticals integrates AI into a Human Factors Study for STENDRA (avanafil), aiming for OTC status. The AI tool, developed with a software developer, assesses safe drug administration. The study, following FDA guidance, evaluates the web app's effectiveness for patient self-screening, supporting STENDRA's potential as the first OTC erectile dysfunction medication.
Reference News
Petros Pharmaceuticals integrates AI into a Human Factors Study for STENDRA (avanafil), aiming for OTC status. The AI tool, developed with a software developer, assesses safe drug administration. The study, following FDA guidance, evaluates the web app's effectiveness for patient self-screening, supporting STENDRA's potential as the first OTC erectile dysfunction medication.